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This results in a Dmin occurring out-of-field at approx. the 
same depth where Dmax occurs in-field. However at 15cm 
from the field edge the second build-up region disappears for 
all detectors. The measured divergent PDDs agree to within 
0.5% of each other over the range of out-of-field distances 
examined. Initial comparison to MC reveal good agreement 
however the MC PDDs have a large statistical uncertainty. 
Conclusions: The detectors used in this study show similar 
response to out-of-field radiation. Concern over the 
predominance of low energy photons out-of-field causing an 
over-response in detectors is not evident in this study. The 
presence of the Dmin could have clinical implications for out-
of-field dose measurements (e.g. scatter diodes measuring 
Dmin). Future work will be completed in comparing the 
measurements and MC to a variety of TPSs to identify the 
accuracy of different TPSs for out-of-field dose. Also 
measurements will be repeated for other clinically available 
detectors and improvements in the statistical uncertainty of 
the MC dose calculation will be completed. 
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Purpose/Objective: Malfunctions of Cardiac Implantable 
Electrical Devices (CIED) have been described in patients 
undergoing radiation therapy. Damage can be observed even 
in the absence of direct exposure to ionizing radiation 
beams, due to diffusion of neutrons (n) causing 'soft error' in 
the CIED circuits. Neutrons are produced by nuclear reaction 
in the head of linear accelerators operating at beam energies 
≥10 MeV and this can be source of pacemaker (PM) and 
implantable defibrillator (ICD) malfunctions. The aim of this 
study is to assess the risk of CIED malfunctions in patients 
undergoing radiation treatment of the pelvic region. 
Materials and Methods: Different models of working CIEDs, 
explanted from patient to prevent battery drain, were placed 
on a neutron tissue equivalent anthropomorphic phantom and 
irradiated with a 15MV photon beam on a VARIAN CLINAC 
2100C linear accelerator, simulating a 3D prostate 
radiotherapy course (70 Gy). Photon radiation and neutron 
doses at the CIED site were measured. A dosimetric film 
GAFCHROMIC-EBT2 was used to quantitatively evaluate the 
radiation gamma-dose absorbed by the CIED. Neutron dose 
was measured with bubble dosimeters for both thermal and 
fast neutrons and CR-39 track etch detectors. The radiation 
emitted by the exposed devices has been used to assess 
whether their activation could be associated with the capture 
of thermal neutrons. For this purpose we used a High Purity 
Germanium detector for gamma spectrometry. All devices 
were measured before and after irradiation. 
Results: Fifty-nine devices, 34 pacemakers (PMs) and 25 
implantable defibrillators (ICDs), were analyzed. No 
malfunctions were detected before irradiation. After 
irradiation a software malfunction was evident in 13 (52%) 
ICDs and 6 (18%) PMs, despite a negligible thoracic X-
radiation dose and no electromagnetic field detected with 
specific EM-field measuring devices. 
The measured neutron dose in the CIED region was 19±4 mSv. 
Neutron capture was demonstrated by the presence of the 
isotope 198Au (197Au+n) or 192Ir (191Ir+n) in the devices and was 
greater in ICD than in PM. 
Conclusions: High energy radiation therapy can determine 
CIED malfunctions even in absence of direct exposure to the 
X-radiation beam, because of the diffusion of neutrons 
produced by the linear accelerator, causing 'soft errors' in the 
circuits. In our experimental model we simulated a complete 
radiotherapy treatment for prostatic cancer on an 
anthropomorphic phantom designed for neutron dosimetry. 
Despite the absence of significant photonic radiation and any 
electromagnetic field in the thoracic zone, some 
malfunctions were detected in 52% of ICDs an 13% of PMs. 
The year of production did not seem to be correlated with 
the risk of PM malfunctions, while damaged ICDs were older 
than those without malfunction. Malfunctions are more 
frequent in ICDs than in pacemakers.  
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Purpose/Objective: An analytical function which models the 
photon peripheral dose as a function of the distance (along 
the craneo-caudal axis) to the isocenter treatment has been 
developed [1] by our group. This model, which also accounts 
for prescription dose to MU ratio and an effective field size, 
was parameterized using standard 6LiF/7LiF pairs of 
dosimeters TLD600-TLD700 calibrated with a 137Cs calibration 
source at secondary standard dosimetry laboratory in CIEMAT 
(Spain). Those measurements had been carried out on a 
whole-body anthropomorphic phantom [2] irradiated with 
3DCFRT, IMRT and VMAT treatments. The model allows 
peripheral dose estimation for any kind of isocentric 
treatment.  
The purpose of this work was to make a validation of our 
analytical model for photon peripheral dose calculation in 
H&N and prostate IMRT treatments, using an independent 
dosimetry system. 
Materials and Methods: Two, H&N and prostate, 6 MV IMRT 
treatment plans (for which our approximation for an 
effective field size might be less accurate), were chosen. A 
Varian 21EX linac unit was used to deliver one treatment 
fraction, with 0.097 cGy/UM and 0.277 cGy/UM to the 
isocenter for the H&N (9 fields) and prostate (7 fields) cases, 
respectively. TLD-100 pairs (calibrated with a 6 MV beam) of 
dosimeters, were placed inside the phantom outside the 
irradiated volume. As dose calibration factors for the TLDs 
were obtained under standard conditions for a 6 MV linac 
spectra, and the measurements carried out in peripheral 
photon spectra inside a medium, uncertainties in dose 
determination could be around 3-5%. Bigger uncertainties 
should be expected in the very low dose tail of doses. 
Our model was used for calculating the dose/MU at the TLD´s 
positions as if these were have been placed at mid thickness 
of the phantom´s thorax (this is a sensible approximation as 
actual depths for different beams might compensate). 
Results: Bars in the Figure, depict the photon dose rates 
measured with the TLD´s pairs as a function of the distance 
to the isocenter along the craneo-caudal direction (1.a and 
1.b for the H&N and prostate cases, respectively). 
Differences with the model estimations are represented by 
the error lines on the top of each bar. An exponential 
behaviour is obtained, as expected. 
For the H&N irradiations, differences between measurements 
and model predictions ranged from 15.6 µSv/MU to -0.1 
µSv/MU. For the prostate case this range was (2.7-0.2) 
µSv/MU. For both cases, in all points except one of them, the 
model overestimated the TLD´s measurements. 
Figure.  
 
Conclusions: Validation of a photon peripheral dose 
calculation model has been carried out against an 
independent setup and dosimetric system. Good agreement 
has been found between our model and the experimental 
measurements. However, our current modelization of the 
influence of the field size can be improved for the IMRT cases 
as the model consistently overestimates the measurements. 
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Purpose/Objective: Recently the risk of secondary cancer 
after advanced radiation therapy has become an important 
issue, especially stochastic effects induced by low-LET 
exposure away from the treated region. The out-of-field 
measurements are sophisticated because of the complexity of 
radiation components (radiation is scattered many times), 
the unknown energy spectrum and the low level of doses. 
These conditions disqualify many detectors which are 
commonly used in clinical dosimetry. The aim of the work 
was to check the response of available detectors in low doses 
outside the treated area, the discussion of the usefulness of 
dosimetric tools and to determine the out-of-field doses for 
photon therapy. 
Materials and Methods: The measurements were done for 6 
and 20 MV delivered with Varian Clinac2300 linear 
accelerator. The dose distributions were obtained using TL 
detectors (TLD100, TLD600, TLD700 Harshaw), radiochromic 
films (Gafchromic EBT). The detectors were placed in a 
specially designed water phantom (40cmx35cmx90cm) on 
8cm depth (SSD=92cm) in 10x10cm2 open field and the total 
dose delivered to the target was 75 Gy. There were several 
measurement points in which the detectors were placed: in 
isocentre (CAX) and outside the field in distance from 
isocentre: P210 cm; P315 cm; P420 cm; P525 cm; P630 cm; P735 
cm. If necessary, correlation coefficients for energy were 
used. Additional doses were compared to TPS calculations 
(AAA alghoritm). 
